PubMed Health⌕ Search

Biomedical subjects

Patrick M Colletti

Publications and source records attributed to Patrick M Colletti.

8 recordsLinked to original sources

MR in patients with pacemakers and ICDs: Defining the issues.

There has been great controversy related to performance of magnetic resonance imaging in patients with pacemakers and implantable cardiac defibrillators. Recent questions have been raised regarding whether contraindications are absolute or relative. Although there are theoretical as well as documented issues relating to device malfunction, data suggest that scanning patients with devices may be feasible when important clinical questions need to be addressed by following strict guidelines. Advanced knowledge and understanding of electrophysiologic as well as magnetic resonance imaging-related issues, and a multidisciplinary, collaborative approach is required to further define the role of MR in patients with pacemakers and implantable cardiac defibrillators.

Artifacts↗

Evaluation of intracardiac shunts with cardiac magnetic resonance.

Intracardiac shunts including atrial septal defect, ventricular septal defect, endocardial cushion defects, and surgical baffles may be identified, localized, and quantified using cardiac MRI methods. Both dark-blood and bright-blood techniques are helpful to identify anatomy. Contrast enhancement is especially useful for identifying associated vascular anomalies. Dynamic first-pass contrast agent signal-time studies may demonstrate rapid recirculation and shunting. Volumetric and phase contrast cine methods are useful to quantify flow. Pulmonary to systemic (Qp/Qs) flow ratios may be calculated noninvasively by comparing the pulmonary artery flow to the aortic flow measurement.

Coronary Circulation↗

FDG PET-CT demonstration of Sjogren's sialoadenitis.

We report the positron emission tomography-computed axial tomography (PET-CT) appearance of the inflammatory involvement of the salivary glands of a 69-year-old female with a history of lymphoma and known primary Sjogren's syndrome. Hybrid PET-CT was performed 5 months after completion of chemotherapy using a Siemens Biograph scanner (Knoxville, TN) 45 minutes after intravenous administration of 15 mCi of F-18 fluorodeoxyglucose (FDG). CT transmission scan was obtained for attenuation correction. PET-CT demonstrated no evidence of hypermetabolic nodal disease but showed symmetric intensely hypermetabolic submandibular and parotid salivary glands.

Aged↗